Autres langues Amgen Inc. Sao Paulo

Actions

AMGN34

BRAMGNBDR004

Produits pharmaceutiques

Marché Fermé - Sao Paulo 21:38:32 14/08/2026			Varia. 5j.	Varia. 1 janv.
77,45 ^BRL	+0,52%		+4,35%	+17,42%

14/08	Amgen : une dirigeante cède des actions pour plus de 1,3 million de dollars, selon un document de la SEC	MT
13/08	Amgen Inc. : Barclays maintient son opinion neutre	ZM

Autres langues

14/08	Amgen Insider Sold Shares Worth $1,346,499, According to a Recent SEC Filing
11/08	Global drugmakers invest billions to boost US presence
10/08	Amgen Insider Sold Shares Worth $1,194,416, According to a Recent SEC Filing
10/08	Amgen Insider Sold Shares Worth $1,565,898, According to a Recent SEC Filing
06/08	Dow closes at record on Mideast optimism; SpaceX, AMD drag Nasdaq
05/08	Aktien New York Schluss: Dow setzt Rekordjagd dank Iran-Hoffnungen fort
05/08	Dow closes at record on Mideast optimism; SpaceX, AMD drag Nasdaq
05/08	Mideast deal hopes lift Dow, S&P to records; SpaceX, AMD drag Nasdaq
05/08	Aktien New York: Iran-Hoffnungen sorgen für Rekorde bei Dow und S&P 500
05/08	Analyst recommendations: Palantir Technologies, McDonald's, Booking Holdings, Arista Networks, Amgen...
05/08	Amgen handily beats consensus in Q2
05/08	Amgen wird erneut etwas optimistischer - Anleger hoch erfreut
04/08	Amgen Lifts Outlook on Strong 2Q Drug Sales, to End Early Development of Obesity Treatment
04/08	Amgen Q2 Adjusted Earnings, Revenue Rise; Lifts 2026 Guidance
04/08	Amgen: Q2 Earnings Snapshot
04/08	(AMGN) Amgen Expects Full Year 2026 Revenue Range $38.2B - $39.4B, vs. FactSet Est of $37.74B
04/08	(AMGN) Amgen Expects Full Year 2026 Adjusted EPS Range $22.30 - $23.50, vs. FactSet Est of $22.36
04/08	Amgen second-quarter sales rise 9%, profit tops Street view
04/08	Earnings Flash (AMGN) Amgen Inc. Posts Q2 Adjusted EPS $6.29 per Share, vs. FactSet Est of $5.62
04/08	Earnings Flash (AMGN) Amgen Inc. Reports Q2 Revenue $10.05B, vs. FactSet Est of $9.43B
04/08	Tranche Update on Amgen Inc.'s Equity Buyback Plan announced on April 21, 2011.
04/08	AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS
04/08	Amgen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
04/08	Amgen Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2026
04/08	Equities Rally Intraday Amid Upbeat Earnings, Hormuz Reopening Hopes